Skip to search formSkip to main contentSkip to account menu

Clofibric Acid

Known as: Propanoic acid, 2-(4-chlorophenoxy)-2-methyl-, Clofibrinic Acid, p-Chlorophenoxyisobutyric Acid 
An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
National Institutes of Health

Related topics

Related topics

22 relations

Narrower (13)

2-(4-chlorophenoxy)butyric acidWKLB 5alfibrateciprofibrate

Broader (2)

Anticholesteremic AgentsHypolipidemic Agents
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Reversible blockage of the cell cycle in the meristem of Riella helicophylla (Bory et Mont.) Mont. by p-chlorophenoxyisobutyric acid (PCIB)
Treatment of gemmae of Riella helicophylla with PCIB results in reversible blockage of the meristematic cells in the G1-phase. At… 
2000
2000
Clofibric acid or diethylmaleate supplemented diet decrease blood pressure in DOCA-salt treated male Sprague-Dawley rats - relation with liver antioxidant status
The effects of 8-week diethylmaleate (DEM) and clofibric acid (CFA) supplemented diet on blood pressure, body and liver weights… 
1989
1989
Sex-related differences in the enhancing effects of perfluoro-octanoic acid on stearoyl-CoA desaturase and its influence on the acyl composition of phospholipid in rat liver. Comparison with…
The effects of the peroxisome proliferators clofibric acid (p-chlorophenoxyisobutyric acid), tiadenol [2,2'-(decamethylenedithio… 
1985
1985
Induction of peroxisomal beta-oxidation enzymes in primary cultured rat hepatocytes by clofibric acid.
Rat hepatocytes were cultured for 72 h with or without the addition of 0.5 mM clofibric acid. The activities of individual… 
1984
1984
[Bezafibrate-induced myolysis and myoglobinuria in patients with impaired renal function].
A muscular syndrome has been described in patients on clofibrate and fenofibrate therapy. The present paper describes four… 
1982
1982
Hypocholesterolemic and antiaggregatory properties of 2-hydroxytetronic acid redox analogues an their relationship to clofibric acid.
A rationale is presented for investigating aci-reductone 2-hydroxytetronic acids as antilipidemic drugs. These compounds are… 
1979
1979
Treatment of hyperlipoproteinemia type II with etofibrate.
Seven patients with hyperlipoproteinemia (HLP) type II (four patients with type II A and three patients with type II B), who were… 
1976
1976
Pharmacokinetic study and bioavailability of three marketed compounds releasing p-chlorophenoxyisobutyric acid (CPIB) in volunteers.
The bioavailability and the pharmacokinetics of three hypolipidemic marketed drugs: clofibride, clofibrate and basic aluminium… 
1976
1976
Quantitative gas-chromatographic flame-ionization method for p-chlorophenoxyisobutyric acid in human serum and saliva.
We describe a gas-chromatographic method for p-chlorophenoxyisobutyric acid (I) the active metabolite of clofibrate. The drug and… 
1968
1968
Sex expression in floral buds of Acorn squash
SummaryStaminate flowers of the Acorn squash (Cucurbita pepo, cv. Table Queen) are initiated monosexually, pistillate flowers are…